Immune cell regulatory pathways

Immune cell regulatory pathways are the integrated networks of molecular signals that dictate the activation, duration, and resolution of immune responses (Pardoll, 2012, Nature Reviews Cancer). These pathways include inhibitory 'checkpoints' like Programmed Cell Death 1 (PD-1) and Cytotoxic T-Lymphocyte Associated Protein 4 (CTLA-4), which maintain self-tolerance by dampening T-cell activity (Pardoll, 2012). In addition to checkpoints, these pathways involve stimulatory signals from Toll-like receptors (TLRs) and various cytokine-mediated cascades like the JAK/STAT pathway (Akira et al., 2006, Cell; O'Shea et al., 2013, NEJM). In many diseases, particularly cancer, these regulatory mechanisms are co-opted to create an immunosuppressive environment, while in autoimmune disorders, they may be insufficiently active. Therapeutic intervention often involves monoclonal antibodies or small molecules designed to either block inhibitory signals or enhance stimulatory ones to restore effective immune function. Because this term refers to a broad set of biological processes and multiple distinct proteins rather than a single molecular entity, it is classified as a pathway category rather than a specific therapeutic target.

Other names

Immune checkpointsImmunomodulatory pathwaysImmune signaling cascadesImmune homeostasis pathways

Modulation of immune cell activation and effector function through the inhibition of negative regulators (checkpoints) or the stimulation of activating signaling cascades.